Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Pasternak

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Annals of Neurology|January 12, 2017
Electrical impedance myography for assessment of Duchenne muscular dystrophySeward B Rutkove, Kush Kapur, Craig M Zaidman, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|November 9, 2016
Loss of electrical anisotropy is an unrecognized feature of dystrophic muscle that may serve as a convenient index of disease statusSeward B Rutkove, Jim S Wu, Craig Zaidman, et al.
Neuromuscular Disorders : NMD|December 4, 2019
A critical review of patient and parent caregiver oriented tools to assess health-related quality of life, activity of daily living and caregiver burden in spinal muscular atrophySonia Messina, Anna Lia Frongia, Laura Antonaci, et al.
Journal of Pediatric Rehabilitation Medicine|March 12, 2016
Physical therapy services received by individuals with spinal muscular atrophy (SMA)Sally Dunaway, Jacqueline Montes, Michael P McDermott, et al.
Journal of Neuro-Oncology|December 14, 2017
Development of the CNS TAP tool for the selection of precision medicine therapies in neuro-oncologyJoseph R Linzey, Bernard L Marini, Amy Pasternak, et al.
Journal of Neuromuscular Diseases|February 13, 2023
Assessing Bulbar Function in Spinal Muscular Atrophy Using Patient-Reported OutcomesSally Dunaway Young, Amy Pasternak, Tina Duong, et al.
Frontiers in Neurology|August 6, 2024
Long-term efficacy, safety, and patient-reported outcomes of apitegromab in patients with spinal muscular atrophy: results from the 36-month TOPAZ studyThomas O Crawford, John W Day, Darryl C De Vivo, et al.
Journal of Clinical Medicine|May 11, 2024
Beyond Contractures in Spinal Muscular Atrophy: Identifying Lower-Limb Joint HypermobilityElizabeth R Harding, Cara H Kanner, Amy Pasternak, et al.
Journal of Neuromuscular Diseases|May 22, 2023
Development of an International SMA Bulbar Assessment for Inter-professional AdministrationSally Dunaway Young, Katlyn McGrattan, Emily Johnson, et al.
Muscle & Nerve|July 13, 2019
Nusinersen improves walking distance and reduces fatigue in later-onset spinal muscular atrophyJacqueline Montes, Sally Dunaway Young, Elena S Mazzone, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Annals of Neurology|January 12, 2017
Electrical impedance myography for assessment of Duchenne muscular dystrophySeward B Rutkove, Kush Kapur, Craig M Zaidman, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|November 9, 2016
Loss of electrical anisotropy is an unrecognized feature of dystrophic muscle that may serve as a convenient index of disease statusSeward B Rutkove, Jim S Wu, Craig Zaidman, et al.
Neuromuscular Disorders : NMD|December 4, 2019
A critical review of patient and parent caregiver oriented tools to assess health-related quality of life, activity of daily living and caregiver burden in spinal muscular atrophySonia Messina, Anna Lia Frongia, Laura Antonaci, et al.
Journal of Pediatric Rehabilitation Medicine|March 12, 2016
Physical therapy services received by individuals with spinal muscular atrophy (SMA)Sally Dunaway, Jacqueline Montes, Michael P McDermott, et al.
Journal of Neuro-Oncology|December 14, 2017
Development of the CNS TAP tool for the selection of precision medicine therapies in neuro-oncologyJoseph R Linzey, Bernard L Marini, Amy Pasternak, et al.
Journal of Neuromuscular Diseases|February 13, 2023
Assessing Bulbar Function in Spinal Muscular Atrophy Using Patient-Reported OutcomesSally Dunaway Young, Amy Pasternak, Tina Duong, et al.
Frontiers in Neurology|August 6, 2024
Long-term efficacy, safety, and patient-reported outcomes of apitegromab in patients with spinal muscular atrophy: results from the 36-month TOPAZ studyThomas O Crawford, John W Day, Darryl C De Vivo, et al.
Journal of Clinical Medicine|May 11, 2024
Beyond Contractures in Spinal Muscular Atrophy: Identifying Lower-Limb Joint HypermobilityElizabeth R Harding, Cara H Kanner, Amy Pasternak, et al.
Journal of Neuromuscular Diseases|May 22, 2023
Development of an International SMA Bulbar Assessment for Inter-professional AdministrationSally Dunaway Young, Katlyn McGrattan, Emily Johnson, et al.
Muscle & Nerve|July 13, 2019
Nusinersen improves walking distance and reduces fatigue in later-onset spinal muscular atrophyJacqueline Montes, Sally Dunaway Young, Elena S Mazzone, et al.
Pageof 6